SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is intensely trending as community sentiment grapples with the fallout from widely discussed high-profile price predictions that did not materialize, leading to a polarized debate. Many express frustration and skepticism, while others maintain strong conviction for its future, highlighting regulatory developments like the Clarity Act. The conversation also circles around declining XRP exchange supply and growing institutional interest through ETFs, balanced against concerns about routine escrow releases as participants look to the new year for potential shifts.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance (AERO) is trending following its Robinhood listing and ongoing discussions around a Velodrome merger, which many believe will solidify its role as a cross-chain DeFi powerhouse. The community is split, with strong conviction calls to "buy the dip" countered by concerns over recent price volatility and token unlock events. As a central liquidity hub for the rapidly expanding Base network, AERO's long-term potential continues to be a hot topic.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals (SPRY) is trending following recent global regulatory approvals for its needle-free epinephrine nasal spray, Neffy, notably in China and Japan, which is fueling commercial momentum. The community is intensely focused on a potential short squeeze due to high short interest and tightening share availability, while also weighing Neffy's market traction against competitive products and its expansion into new indications like hives. This positions SPRY as a significant disruptor in the rapidly evolving anaphylaxis treatment landscape.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending amidst a surprising price rally, sparking widespread community speculation about its cause. Discussions revolve around potential strategic developments like a Mastercard/Zero Hash merger and its increasing real-world utility with major retailers through Flexa, while many caution against another short-lived pump-and-dump given its historical volatility.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena &gt; Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

COCK CRYPTO is generating significant buzz as its community actively discusses the integration of real-world assets through CockyWingsLLC, which sells chicken wings to create revenue and buybacks for token holders. This unique approach, combined with a new Memes Hub DAPP, is seen by the passionate "Flock" as a genuine utility play, providing passive gains and aiming to distinguish itself within the Cardano ecosystem.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

Sprott Physical Silver Trust (PSLV) is trending as the community speculates on a looming 'silver squeeze,' driven by escalating industrial demand, upcoming Chinese export controls, and recent market dynamics like increased margin requirements and reported bank short covering. Many investors view PSLV as a superior alternative to traditional paper-backed silver ETFs, believing sustained manipulation is unsustainable and anticipating a significant revaluation of physical silver as a critical mineral.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow Jones Industrial Average is trending amidst contrasting community views on market direction, with some anticipating a year-end rally and continued strength, while others express concerns about potential corrections and AI-related valuations. This debate is largely driven by ongoing Federal Reserve deliberations over future rate adjustments and the broader economic outlook, alongside observed shifts in investor focus across different sectors.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is surging due to the FDA granting Priority Review for its AXS-05 supplemental New Drug Application for Alzheimer's disease agitation, signaling an accelerated review timeline. This significant regulatory clarity, coupled with positive pre-NDA feedback for AXS-12 in narcolepsy, has ignited widespread excitement among long-term investors. The community is actively discussing the stock's substantial price and volume increase, viewing these developments as a major validation for Axsome's robust CNS pipeline within the dynamic biotech sector.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is trending as recent dividend distributions are causing investor confusion and frustration over a perceived price drop and significant underperformance compared to its underlying asset, SMCI. Despite community concerns about decay and potential reverse splits, many view current levels as an attractive buying opportunity for this leveraged AI infrastructure ETF, anticipating a rebound. The fund's amplified volatility and divergence from SMCI's movement continue to fuel intense debate among traders.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as its new Prediction Markets platform recently launched, expanding its addressable market into states without legalized sports betting. The community is actively discussing the potential revenue boost from this expansion, alongside a favorable streak of sports outcomes that suggest a strong quarter for its traditional sportsbook. Despite enthusiasm for these growth catalysts and increased exposure from streaming partnerships, many investors remain frustrated by the stock's recent price stagnation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the fourteen brokerages that are presently covering the stock...

Structure Therapeutics (NASDAQ:GPCR) Shares Down 3.3% - Here's Why

Structure Therapeutics (NASDAQ:GPCR) Shares Down 3.3% - Here's Why...

NVO's First Oral Obesity Pill Approval: What Does it Mean for Lilly?

NVO secures FDA approval for its first oral obesity pill, Wegovy, giving it a first-to-market edge and raising questions about Lilly's next move.

Structure Therapeutics (NASDAQ:GPCR) Stock Price Up 5.2% - Here's Why

Structure Therapeutics (NASDAQ:GPCR) Shares Up 5.2% - Time to Buy...

Novo Nordisk Wins FDA Nod for Oral Wegovy in Obesity, Stock Up

NVO stock up as it wins FDA approval for oral Wegovy in obesity, becoming the first oral GLP-1 RA indicated for weight management.

What Awaits These 4 Biotech Stocks That More Than Doubled in 2025

IONS, GPCR, MNPR and KOD more than double in 2025 as policy clarity, M&A revival and clinical wins lift biotech momentum into 2026.

Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up - Still a Buy?

Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up - Here's What Happened...

Structure Therapeutics (NASDAQ:GPCR) Stock Price Down 8.5% - Should You Sell?

Structure Therapeutics (NASDAQ:GPCR) Shares Down 8.5% - Here's Why...

CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval

NVO gains CHMP backing for a higher-dose Wegovy, paving the way for potential EU approval in 2026 as study data show stronger weight loss.

Bellevue Group AG Acquires 126,812 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR

Bellevue Group AG lifted its stake in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Free Report) by 57.2% during the second quarter, according to the company in its most recent 13F filing...

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Current Price	$69.55
Prev Close	$67.78
Open	$67.70
Dividend Yield	0.00%
50-Day Moving Average	$44.29
Beta	1.03
Avg. Volume	1.25M
PE Ratio	-19.04

52-Week High	$94.90
52-Week Low	$13.22
Market Capitalization	$4.91B
EPS (Annual)	-$2.33
Price to Book	5.48
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

GPCR
Structure Therapeutics Inc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GPCR News

GPCRStructure Therapeutics Inc - ADR